MPO and interstitial lung disease: A Japanese study demonstrated that mucin 5B (MUC5B) promoter polymorphism is associated with an increased risk of ILD, more severe lung involvement, and increased pulmonary fibrosis in patients with MPO-ANCA vasculitis [52].